Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 2356 AL 2370

Use of AR/VR for Treatment of Freezing of Gait (FoG) in Parkinson's Disease (PD)

Pokharel A, Tamrakar A, Chopra N.

J Clin Med. 2026 Mar 9;15(5):2076. doi: 10.3390/jcm15052076.

Research Progress on the Mechanism of Ginsenosides in the Treatment of Parkinson's Disease

Wang S, Chen Z, Tang H, Gong J, Xu K, Wang K.

Int J Mol Sci. 2026 May 19;27(10):4544. doi: 10.3390/ijms27104544.

Meta analysis of glucose metabolism across Alzheimer's, Parkinson's and ALS Reveals emergence of adaptive brain glucometabolic responses and associated neurological functional profiles

Raikes AC, Garza M, Murrell AN, Brinton RD.

medRxiv [Preprint]. 2026 Apr 8:2026.04.07.26350339. doi: 10.64898/2026.04.07.26350339.

Cytokine associated neuroinflammation in Parkinson's disease: Molecular pathways, therapeutic targets, and translational insights

Dhapola R, Kumari S, Sharma P, Paidlewar M, Vellingiri B, Medhi B, HariKrishnaReddy D.

Cytokine Growth Factor Rev. 2026 Apr;88:1-17. doi: 10.1016/j.cytogfr.2026.01.001. Epub 2026 Jan 5.

Phosphodiesterase 4 as a therapeutic target in Parkinson's disease recent advances

Zhong J, Xu J, Xue J, Qiu Z, Chen B, Yu X, Lin Z.

Exp Neurol. 2026 Jun;400:115680. doi: 10.1016/j.expneurol.2026.115680. Epub 2026 Feb 9.

[Acteoside: neurobiological activity spectrum, potential in the treatment of age-associated neurodegenerative diseases]

Berezutsky MA, Andronova TA, Belonogova YV, Durnova NA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4):41-47. doi: 10.17116/jnevro202612604141.

Exosomes Regulate the NLRP3/Caspase-1/IL-1β Signaling Pathway in Parkinson's Disease: Mechanisms of Neuroinflammation Modulation and α-Synuclein Propagation

Zhang T, Du H, Wang S.

Neuropsychiatr Dis Treat. 2026 Feb 28;22:587802. doi: 10.2147/NDT.S587802. eCollection 2026.

Trends in Nanoparticle-based Strategies for the Management of Neuroinflammation

Rana A, Malviya R, Rajput S, Sridhar SB, Wadhwa T.

CNS Neurol Disord Drug Targets. 2026;25(1):39-55. doi: 10.2174/0118715273373041250707012835.

Collaborative action for biomarker breakthroughs: Validating α-synuclein seed amplification assays in Parkinson's disease

Oliveira LM, Frasier M, Hutten SJ.

J Parkinsons Dis. 2026 Mar 19:1877718X261431949. doi: 10.1177/1877718X261431949. Online ahead of print.

Rare Presentation of TEN-Like Subacute Cutaneous Lupus Erythematosus Occurring in the Setting of Donepezil Exposure and COVID-19 Infection: A Diagnostic Challenge

Kenney S, Acosta A, Castillo J, Cassarino D, Yang A.

J Cutan Pathol. 2026 Oct;53(10):946-954. doi: 10.1111/cup.70109. Epub 2026 May 11.

Advances in sex-specific single-cell transcriptomic profiling in Parkinson's disease

Hoof V, Schulze-Hentrich J.

J Parkinsons Dis. 2026 May 5:1877718X261436548. doi: 10.1177/1877718X261436548. Online ahead of print.

Using Digital Outcomes to Measure Meaningful Aspects of Health in Clinical Trials for Parkinson's Disease: A Scoping Review

van Es MJ, Timmermans NA, Meinders MJ, Nolen WA, Bloem BR, Shin S, Boenink M, Evers LJW.

Digit Biomark. 2026 Mar 19;10(1):90-102. doi: 10.1159/000550956. eCollection 2026 Jan-Dec.

Epidemiology of Parkinson's disease - Global burden of disease research from 1990 to 2021 and future trend predictions

Wang S, Che Y, Lin Y, Zhang Y, He W, Zhang W.

Clin Park Relat Disord. 2026 Jan 9;14:100421. doi: 10.1016/j.prdoa.2026.100421. eCollection 2026.

Proper name anomia in people with Alzheimer's disease: implications for diagnosis and treatment-a systematic review

Badalova A, Stott J, Leff AP.

NPJ Dement. 2026;2(1):11. doi: 10.1038/s44400-026-00058-y. Epub 2026 Feb 2.

Real-Time ECG Artifact Removal for Adaptive Deep Brain Stimulation: A Comparative Study

Silvi L, D'Onofrio V, Cauzzo S, Antonini A, Guerra A, Porcaro C.

Sensors (Basel). 2026 Apr 25;26(9):2673. doi: 10.3390/s26092673.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias